These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26137530)

  • 21. First FDA authorization for next-generation sequencer.
    Collins FS; Hamburg MA
    N Engl J Med; 2013 Dec; 369(25):2369-71. PubMed ID: 24251383
    [No Abstract]   [Full Text] [Related]  

  • 22. ClinVar: public archive of relationships among sequence variation and human phenotype.
    Landrum MJ; Lee JM; Riley GR; Jang W; Rubinstein WS; Church DM; Maglott DR
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D980-5. PubMed ID: 24234437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actionable, pathogenic incidental findings in 1,000 participants' exomes.
    Dorschner MO; Amendola LM; Turner EH; Robertson PD; Shirts BH; Gallego CJ; Bennett RL; Jones KL; Tokita MJ; Bennett JT; Kim JH; Rosenthal EA; Kim DS; ; Tabor HK; Bamshad MJ; Motulsky AG; Scott CR; Pritchard CC; Walsh T; Burke W; Raskind WH; Byers P; Hisama FM; Nickerson DA; Jarvik GP
    Am J Hum Genet; 2013 Oct; 93(4):631-40. PubMed ID: 24055113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.
    Green RC; Berg JS; Grody WW; Kalia SS; Korf BR; Martin CL; McGuire AL; Nussbaum RL; O'Daniel JM; Ormond KE; Rehm HL; Watson MS; Williams MS; Biesecker LG;
    Genet Med; 2013 Jul; 15(7):565-74. PubMed ID: 23788249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project.
    Biesecker LG
    Genet Med; 2012 Apr; 14(4):393-8. PubMed ID: 22344227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rubinstein-Taybi syndrome: clinical and molecular overview.
    Roelfsema JH; Peters DJ
    Expert Rev Mol Med; 2007 Aug; 9(23):1-16. PubMed ID: 17942008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole Genome Sequencing in Cancer Clinics.
    Chen K; Meric-Bernstam F
    EBioMedicine; 2015 Jan; 2(1):15-6. PubMed ID: 26137530
    [No Abstract]   [Full Text] [Related]  

  • 28. Catalogue, cause, complexity and cure; the many uses of cancer genome sequence.
    Wooster R; Bachman KE
    Curr Opin Genet Dev; 2010 Jun; 20(3):336-41. PubMed ID: 20382522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cancer genome analysis through next-generation sequencing].
    Aburatani H
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):1-6. PubMed ID: 21368453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling.
    O'Daniel JM; Lee K
    Cancer J; 2012; 18(4):287-92. PubMed ID: 22846728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors.
    Morozova O; Marra MA
    Biochem Cell Biol; 2008 Apr; 86(2):81-91. PubMed ID: 18443621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic cancer genome sequencing and the contribution of germline variants.
    Kilpivaara O; Aaltonen LA
    Science; 2013 Mar; 339(6127):1559-62. PubMed ID: 23539595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the genetics of cancer: genome sequencing and beyond.
    Wong KM; Hudson TJ; McPherson JD
    Annu Rev Genomics Hum Genet; 2011; 12():407-30. PubMed ID: 21639794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Whole-genome sequencing: a new approach for understanding of pathogenesis and individualized treatment of cancer].
    Pan Y; Zhang W; Chen S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 42(1):103-8. PubMed ID: 23505116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive genome sequencing of the liver cancer genome.
    Nakagawa H; Shibata T
    Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does massively parallel DNA resequencing signify the end of histopathology as we know it?
    Aparicio SA; Huntsman DG
    J Pathol; 2010 Jan; 220(2):307-15. PubMed ID: 19921711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding genomic alterations in cancer genomes using an integrative network approach.
    Wang E
    Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks.
    Wang E; Zou J; Zaman N; Beitel LK; Trifiro M; Paliouras M
    Semin Cancer Biol; 2013 Aug; 23(4):279-85. PubMed ID: 23791722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What can exome sequencing do for you?
    Majewski J; Schwartzentruber J; Lalonde E; Montpetit A; Jabado N
    J Med Genet; 2011 Sep; 48(9):580-9. PubMed ID: 21730106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.